Literature DB >> 1780767

Thrombogenicity associated with factor IX complex concentrates.

J M Lusher1.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1780767

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  12 in total

Review 1.  Management of hemophilia in developing countries.

Authors:  R Kashyap; V P Choudhry
Journal:  Indian J Pediatr       Date:  2001-02       Impact factor: 1.967

Review 2.  Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

3.  Three-factor prothrombin complex concentrates for refractory bleeding after cardiovascular surgery within an algorithmic approach to haemostasis.

Authors:  Nazish K Hashmi; Kamrouz Ghadimi; Amudan J Srinivasan; Yi-Ju Li; Robert D Raiff; Jeffrey G Gaca; Adam G Root; Yaron D Barac; Thomas L Ortel; Jerrold H Levy; Ian J Welsby
Journal:  Vox Sang       Date:  2019-04-02       Impact factor: 2.144

Review 4.  Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases.

Authors:  Antonio Girolami; Raffaella Scandellari; Ezio Zanon; Roberto Sartori; Bruno Girolami
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

Review 5.  Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity.

Authors:  Benny Sørensen; Donat R Spahn; Petra Innerhofer; Michael Spannagl; Rolf Rossaint
Journal:  Crit Care       Date:  2011-01-12       Impact factor: 9.097

Review 6.  Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in hemaophilia B: a critical evaluation of reported cases.

Authors:  A Girolami; M L Randi; E Ruzzon; E Zanon; B Girolami
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

Review 7.  Warfarin reversal in anticoagulant-associated intracerebral hemorrhage.

Authors:  Joshua N Goldstein; Jonathan Rosand; Lee H Schwamm
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 8.  Recombinant activated factor VII in clinical practice: a 2014 update.

Authors:  Massimo Franchini; Silvia Crestani; Francesco Frattini; Cinzia Sissa; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

9.  Management of bleeding following major trauma: a European guideline.

Authors:  Donat R Spahn; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Giovanni Gordini; Philip F Stahel; Beverley J Hunt; Radko Komadina; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

10.  Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.

Authors:  Pablo Rendo; Janice Lamb; Lynne Smith; Joanne Fuiman; Joan M Korth-Bradley
Journal:  Blood Coagul Fibrinolysis       Date:  2018-01       Impact factor: 1.276
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.